FDA Approved: EVOMELA — Supplemental Application (Acrotech Biopharma Inc)

View source ↗

Summary

The FDA has approved a supplemental NDA for EVOMELA (liposomal melphalan) submitted by Acrotech Biopharma Inc. The approval updates the product labeling and/or …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• EVOMELA (melphalan hydrochloride)

Snippet

SUPPL AP for EVOMELA (MELPHALAN)